Search results for "From ACP Internist"

Results 31 - 40 of about 69 for "From ACP Internist".
Sort by: Relevance | Newest | Oldest

SGLT2 inhibitors associated with rare, life-threatening necrotizing genital infections

In the past six years, nearly three times as many cases of Fournier gangrene were reported in patients taking sodium-glucose cotransporter-2 (SGLT2) inhibitors as in the past 35 years in patients taking other antiglycemic agents.
10 May 2019

New insulins present benefits, challenges

The July/August ACP Internist summarizes expert advice on treating diabetes with new types of insulin.
15 Jul 2016

Expert panel recommends SGLT2 inhibitor or GLP-1 receptor agonist for patients with type 2 diabetes and CVD

The American College of Cardiology's new decision pathway also calls for repeated HbA1c screening and detailed clinician-patient risk discussions for patients with cardiovascular disease (CVD) who are diagnosed with type 2 diabetes.
14 Dec 2018

Antidepressants associated with decreased mortality rates in patients with diabetes and depression

A retrospective cohort study in Taiwan found that antidepressant use was associated with a significantly reduced risk for death, and after adjustment, total mortality decreased as total cumulative antidepressant dose increased.
12 Jul 2019

Text messages may improve glycemic control in patients with diabetes and coronary disease

Patients in a Chinese study received six automated text messages per week with educational and motivational information on glucose monitoring, blood pressure control, medication adherence, physical activity, and lifestyle.
13 Sep 2019

Diabetes outcomes similar when primary care provided by NPs, PAs, or physicians, study finds

More care by nurse practitioners (NPs) and physician assistants (PAs) may be a way to expand primary care access while maintaining quality standards.
14 Dec 2018

New guideline offers recommendations for older patients with diabetes or prediabetes

The Endocrine Society's new clinical practice guideline recommends lifestyle therapy, then metformin, then second-line drugs (but not sulfonylureas and glinides) or insulin for diabetes patients ages 65 years and older, among other advice.
5 Apr 2019

ACP recommends less intensive glucose control in most cases of type 2 diabetes

The evidence-based guidance statement from ACP calls for personalized goals and an HbA1c target between 7% and 8% for most patients with type 2 diabetes.
9 Mar 2018

Lower glucose levels before hospital discharge associated with readmission, death in diabetes patients

Even near-normal glucose levels on the last day of hospitalization were associated with increased risk for readmission and postdischarge mortality, and these risks increased as patients' glucose levels decreased.
10 May 2019

Canagliflozin may not increase fracture risk in patients at low risk for fractures

Although canagliflozin has been linked to decreased bone mineral density, patients with type 2 diabetes who initiated the drug had similar risk of a first fracture as those who started a glucagon-like peptide-1 receptor agonist.
11 Jan 2019

Result Page: Prev   1   2   3   4   5   6   7   Next